Stuart Cook retweeted
Replying to @ImmunoFever @stuartacook1 @MartinBJensen @aa_widjaja @metapredict @MitoPsychoBio @KSadtler
And to keep these thoughts in one🧵: I really think this exciting new understanding of the impacts of IL-11 signaling will help us better understand how Th2-type responses could drive #IACI. There's much metabolic overlap between these illnesses and aging.
ncbi.nlm.nih.gov/pmc/article…
Stuart Cook retweeted
The David Sinclair (@davidasinclair) $720,000,000 Resveratrol Train Wreck
Video shoutouts:
- Prof. Matt Kaeberlein (@mkaeberlein)
- Prof. Brian Kennedy (@BKennedy_aging)
- Dr. Peter Attia (@PeterAttiaMD)
- Prof. Richard Miller
- Prof. Jeffery Flier (@jflier)
Stuart Cook retweeted
Obesity treatment from Boehringer Ingelheim, Zealand Pharma $ZEAL succeeds in study in liver condition MASH statnews.com/2024/02/26/obes… via @DrewQJoseph
Stuart Cook retweeted
A ground-breaking study led by @unibirmingham & @UniFAU reveals that #Fibroblast cells hold the key to resolving joint inflammation 🔑
The discovery could revolutionise future #Arthritis treatments 🔬
➡️bit.ly/3TaTrwe
#Inflammation #Ageing #Research
Stuart Cook retweeted
"The average R&D efficiency of big pharma was $6.16 billion total R&D expenditures per new drug." 😱 And remember, that's the average, meaning ~half are higher than that! @ideapharma $XBI sciencedirect.com/science/ar…
Stuart Cook retweeted
Violence against women & girls remains one of most prevalent & pervasive human rights violations. Globally, estimated 736M women almost 1:3 subjected physical and/or sexual intimate partner violence, non-partner sexual violence or both, at least once life. un.org/en/observances/ending…
Stuart Cook retweeted
Only 12% of drug approvals in the past 6 years were internally-developed Big Pharma programs! @timmermanreport @LifeSciVC
Stuart Cook retweeted
Any guesses on what our next XPRIZE competition will be for? History will be made on Nov. 29 at 10:30am ET / 7:30am PT when we announce the launch of our largest prize ever. You don’t want to miss out. Register to join the livestream of our launch here. xprize.org/health
Stuart Cook retweeted
Color me surprised: another AI drug company making the great migration from an external partnership/ platform model to internal pipeline.
Atomwise signed >750 partnerships 🤯
“But none of those molecules have made it to the clinic.”
From @AndrewE_Dunn’s coverage in Endpoints, summarized in Decoding Bio.
Stuart Cook retweeted
Human senescent fibroblasts trigger progressive lung fibrosis in mice
aging-us.com/article/204825
Stuart Cook retweeted
Fibrogen’s phase 3 ZEPHYRUS-1 shows no effect on FVC at 48 weeks. Sad to see another drug fail at such a late stage, but a fantastic effort to deliver this study! We must learn and move forwards #cureipf @ActionPFcharity @asthmalunguk investor.fibrogen.com/news-r…
Stuart Cook retweeted
On Sunday at the ADA meeting in San Diego I’ll announce the results of our IL-2 trial to slow up the loss of insulin production in children newly diagnosed with type 1 diabetes.
Stuart Cook retweeted
Current and investigational medications for the treatment of sarcopenia
sciencedirect.com/science/ar…
Stuart Cook retweeted
We bet you've been waiting for this announcement! Wait no more - FinnGen DF9 (N=377,277) GWAS results and summary statistics are now freely available! You can browse the results with our web browser and/or download them.
More info:
finngen.fi/en/access_results
#OpenScience #Genomics
Stuart Cook retweeted
As a result of our partnership with Enleofen, we have launched clinical development of our first-in-class IL-11 inhibitor antibody BI 765423, which aims to improve patient outcomes in fibrotic diseases.
Learn more: https://nitter.cf/t.co/vM79HEwmM3
#Innovation
Stuart Cook retweeted
Eighty years ago today – April 26th 1943 – Philip Alexander Poole-Wilson was born. He became a pioneer in the field of heart failure and one of 🇬🇧's most cherished academic cardiologists
With family permission, this 🧵remembers ‘PPW’ and his invaluable contributions to medicine
Stuart Cook retweeted
"Why do you love biotech?"
When Stelios Papadopoulos, aka the Godfather of biotech, was once asked this question, he said:
"What intrigues me the most is this whole process of taking a casual idea in the lab.
Sometimes you sit with a cup of coffee and you say, gee, how about this?
And then, 25 years later, there's somebody with kidney cancer who responds to a drug...
That only happened because of this unique interplay of basic scientists, drug developers, clinical scientists, people betting money on stocks, people who build companies, regulators, journalists, writers, and movie makers.
It's a fascinating laboratory that's multidisciplinary and highly complex.
And all of this, in the end, is for something good.
Lives are saved, pain is relieved.
I don't think there's anything more fascinating than this in life.
There is fascinating stuff, eg. understanding string theory.
It's intellectually, and potentially satisfying, but it's hard to see the immediate positive effect on human life..."
(from @NatureBiotech's First Rounders Podcast with Brady Huggett)
Stuart Cook retweeted
Latest from our lab co-led by Ben Ng, and a continuation of our previous aorta story! 🥳
🍾To my first last author research paper and first-time publication in ATVB 🥂
Grateful to my mentor @stuartacook1, and thankful to the editors/reviewers for their helpful suggestions! ☺️
Genetic and antibody-mediated neutralization of Interleukin-11 attenuates emphysematous lung disease in a mouse model of Marfan Syndrome @WeiWenLim23 @stuartcook1
ahajrnls.org/40ive8i






























